Clover Health posts Q1 GAAP net income of $27M; revenue up 62% YoY

CLOVER HEALTH INVESTMENTS, CORP. /DE

2026-Q1 EPS reported $0.05 revenue$749,189,000

GAAP net income $27.3M vs $(1.3)M in Q1 2025; first positive GAAP net income quarter.
Total revenue $749M (+62% YoY); Medicare Advantage membership 155,773 (+51% YoY).
Consolidated Gross Profit $159.5M (+47% YoY); Adjusted EBITDA $40.3M (+56% YoY).
Full-year 2026 guidance: revenue $2.81B-$2.92B, GAAP net income $0M-$20M.
Expects to meet or exceed full-year outlook with first full year of GAAP net income profitability.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CLOVER HEALTH INVESTMENTS, CORP. /DE reported the first quarter ended March 31, 2026 results: revenue $749 million, net income $27 million. Guidance reaffirmed.

Period: the first quarter ended March 31, 2026
Revenue: $749 million
Net income: $27 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

First quarter 2026 GAAP Net Income of $27 million, an improvement of $29 million year-over-year • First quarter 2026 Medicare Advantage membership of 155,773, up 51% year-over-year, and Total revenues of $749 million, up 62% year-over-year

View on SEC.gov

Browse all earnings releases →

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-26-000114

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.